ClariVest Asset Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-82,200
| Closed | -$661K | – | 810 |
|
|
2018
Q2 | $661K | Buy |
82,200
+700
| +0.9% | +$5.63K | 0.01% | 489 |
|
|
2018
Q1 | $608K | Buy |
81,500
+2,000
| +3% | +$14.9K | 0.01% | 480 |
|
|
2017
Q4 | $473K | Sell |
79,500
-106,674
| -57% | -$635K | 0.01% | 495 |
|
|
2017
Q3 | $1.37M | Buy |
186,174
+24,266
| +15% | +$179K | 0.03% | 318 |
|
|
2017
Q2 | $1.1M | Buy |
161,908
+16,941
| +12% | +$115K | 0.03% | 329 |
|
|
2017
Q1 | $1.37M | Buy |
+144,967
| New | +$1.37M | 0.03% | 313 |
|